Filing Details
- Accession Number:
- 0001209191-20-057275
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-06 16:09:44
- Reporting Period:
- 2020-11-04
- Accepted Time:
- 2020-11-06 16:09:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Chief Adm, Leg & Bd Off | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-04 | 2,330 | $86.52 | 29,168 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-04 | 630 | $215.16 | 28,538 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-04 | 600 | $217.20 | 27,938 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-04 | 600 | $218.63 | 27,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-04 | 300 | $220.10 | 27,038 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-04 | 200 | $221.25 | 26,838 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-04 | 2,330 | $0.00 | 2,330 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,330 | 2027-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $215.16 (range $215.00 to $215.67).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $217.20 (range $216.83 to $217.65).
- Open market sales reported on this line occurred at a weighted average price of $218.63 (range $218.08 to $218.95).
- Open market sales reported on this line occurred at a weighted average price of $220.10 (range $219.78 to $220.56).
- Open market sales reported on this line occurred at a weighted average price of $221.25 (range $221.09 to $221.42).
- The option vests in 16 quarterly installments from 02/03/2017.
Billionaire Hedge Funds
